Lauren Simpson Selected Research

Fever (Fevers)

1/2018

Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lauren Simpson Research Topics

Disease

6	Melanoma (Melanoma, Malignant) 03/2023 - 01/2018
2	Wounds and Injuries (Trauma) 12/2023 - 08/2016
1	Cysts 11/2021
1	Headache (Headaches) 01/2018
1	Fever (Fevers) 01/2018
1	Disease Progression 01/2018
1	Chills 01/2018
1	Fracture Dislocation 08/2016
1	Rotator Cuff Tear Arthropathy 10/2012
1	Neoplasms (Cancer) 10/2011

Drug/Important Bio-Agent (IBA)

3	NivolumabIBA 03/2023 - 11/2018
3	Immune Checkpoint InhibitorsIBA 12/2018 - 11/2018
2	relatlimabIBA 03/2023 - 11/2022
1	N-acetyltalosaminuronic acid (NAT)IBA 12/2023
1	Growth Hormone (Somatotropin)IBA 11/2021
1	IpilimumabIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 11/2018
1	trametinibIBA 01/2018
1	dabrafenibIBA 01/2018
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018

Therapy/Procedure

2	Therapeutics 11/2021 - 01/2018
1	Seat Belts (Seat Belt) 08/2016
1	Arthroplasty 10/2012
1	Hemiarthroplasty 10/2012
1	Laminectomy 10/2011